Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-01 |
2024-03 |
-0.76 |
-0.76 |
N/A |
N/A |
2024-02-28 |
2023-12 |
-0.44 |
-0.32 |
0.12 |
27.27% |
2024-02-28 |
2023-12 |
-0.44 |
N/A |
N/A |
N/A |
2023-11-01 |
2023-09 |
-0.69 |
-0.86 |
-0.17 |
-24.64% |
2023-11-01 |
2023-09 |
-0.69 |
N/A |
N/A |
N/A |
2023-08-02 |
2023-06 |
-0.43 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-03 |
Morgan Stanley |
Upgrade |
Equal-Weight |
Equal-Weight |
2023-08-02 |
BMO Capital |
Upgrade |
Outperform |
Outperform |
2023-06-28 |
Morgan Stanley |
Upgrade |
Equal-Weight |
Equal-Weight |
2023-05-07 |
Citigroup |
Upgrade |
|
Buy |
2023-03-09 |
Morgan Stanley |
Upgrade |
|
Equal-Weight |
2023-02-28 |
BMO Capital |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2024-02-11 |
ABEL ROBERT LORNE |
Officer |
9.34K |
Sale |
2023-06-14 |
CHODAKEWITZ JEFFREY |
Director |
6.25K |
Stock Award(Grant) |
2023-08-08 |
DUGAN HAN M.D. |
Officer |
15.00K |
Stock Award(Grant) |
2023-06-14 |
GINSBERG GARY L |
Director |
6.25K |
Stock Award(Grant) |
2024-03-03 |
HERMAN JENNY |
Officer |
19.07K |
Stock Award(Grant) |
2024-03-05 |
LORTON KENNETH PATRICK |
Officer |
42.06K |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Blackrock Inc. |
8.44M |
421.27M |
13.46% |
2023-06-29 |
Bill & Melinda Gates Foundation Trust |
6.98M |
348.52M |
11.13% |
2023-06-29 |
Vanguard Group Inc |
6.67M |
332.96M |
10.63% |
2023-06-29 |
Baillie Gifford and Company |
2.97M |
148.08M |
4.73% |
2023-09-29 |
ARK Investment Management, LLC |
2.84M |
80.17M |
4.52% |
2023-06-29 |
Nikko Asset Management Americas, Inc. |
2.43M |
121.11M |
3.87% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
iShares Core S&P Smallcap ETF |
3.68M |
104.15M |
5.87% |
2023-09-29 |
ARK ETF Tr-ARK Genomic Revolution ETF |
2.81M |
79.42M |
4.48% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
1.97M |
98.44M |
3.14% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
1.61M |
80.36M |
2.57% |
2023-08-30 |
iShares Russell 2000 ETF |
1.24M |
45.82M |
1.98% |
2023-06-29 |
Vanguard Small-Cap Growth Index Fund |
922.07K |
46.03M |
1.47% |